Tuesday, 17 November 2026 SEC EDGAR filings, as they land
ALFA USA News Straight from the SEC filing
SEC Filings

Arcus Biosciences, Inc. — Latest News

Every SEC filing by Arcus Biosciences, Inc. that we have reported, newest first. Each story links the original filing.

NYSE: RCUS · Biotechnology · 2 stories

Share price
$18.52
Market cap
$2.4B
Revenue (annual)
$247M

Reference market data from a third-party provider, as of the most recent story (23 Oct 2026). Not a valuation or a recommendation.

Arcus Biosciences, Inc. share price · last month
Line chart of Arcus Biosciences, Inc.'s share price over the last month, from $22.14 on 19 Oct → $16.86 on 16 Nov.

Down 23.8% over the last month ($22.14 on 19 Oct → $16.86 on 16 Nov). Daily closing prices. Source: Yahoo Finance.

Show the prices
19 Oct$22.14
20 Oct$23.75
21 Oct$19.10
22 Oct$19.36
23 Oct$18.54
26 Oct$17.76
27 Oct$18.14
28 Oct$18.39
29 Oct$18.61
30 Oct$18.19
2 Nov$17.85
3 Nov$18.91
4 Nov$19.31
5 Nov$17.69
6 Nov$18.28
9 Nov$18.95
10 Nov$18.67
11 Nov$18.80
12 Nov$17.77
13 Nov$17.43
16 Nov$16.86
Capital Raise 1Other 1

Track Arcus Biosciences, Inc. live

Get the next Arcus Biosciences, Inc. SEC filing seconds after it lands.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.